Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 177 | VacciMonitor | journal | 0.101 Q4 | 5 | 11 | 46 | 229 | 4 | 43 | 0.00 | 20.82 |  |
| 176 | Cellular Therapy and Transplantation | journal | 0.103 Q4 | 8 | 47 | 10 | 560 | 1 | 8 | 0.10 | 11.91 |  |
| 175 | Chinese Journal of Cancer Biotherapy | journal | 0.103 Q4 | 5 | 75 | 361 | 1868 | 17 | 342 | 0.03 | 24.91 |  |
| 174 | Journal of Global Trends in Pharmaceutical Sciences | journal | 0.105 Q4 | 1 | 4 | 5 | 86 | 0 | 5 | 0.00 | 21.50 |  |
| 173 | Current Biomarkers | journal | 0.106 Q4 | 3 | 14 | 0 | 713 | 0 | 0 | 0.00 | 50.93 |  |
| 172 | Current Molecular Imaging | journal | 0.108 Q4 | 2 | 0 | 5 | 0 | 2 | 5 | 0.40 | 0.00 | |
| 171 | Gene Therapy and Molecular Biology | journal | 0.108 Q4 | 18 | 0 | 43 | 0 | 8 | 43 | 0.12 | 0.00 |  |
| 170 | Open Pharmacology Journal | journal | 0.108 Q4 | 6 | 0 | 4 | 0 | 0 | 3 | 0.00 | 0.00 | |
| 169 | Current Pharmacogenomics and Personalized Medicine | journal | 0.118 Q4 | 20 | 15 | 79 | 872 | 24 | 73 | 0.24 | 58.13 |  |
| 168 | Open Bioactive Compounds Journal | journal | 0.119 Q4 | 6 | 0 | 4 | 0 | 3 | 4 | 0.00 | 0.00 | |
| 167 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.120 Q4 | 16 | 47 | 127 | 1750 | 30 | 127 | 0.28 | 37.23 |  |
| 166 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.136 Q4 | 14 | 23 | 68 | 1447 | 12 | 60 | 0.08 | 62.91 | |
| 165 | International Journal of Medicinal Chemistry | journal | 0.141 Q4 | 4 | 3 | 3 | 106 | 1 | 3 | 0.33 | 35.33 | |
| 164 | Turkish Journal of Pharmaceutical Sciences | journal | 0.157 Q4 | 22 | 39 | 115 | 1223 | 40 | 115 | 0.30 | 31.36 |  |
| 163 | Journal of Experimental Pharmacology | journal | 0.162 Q4 | 23 | 8 | 6 | 369 | 8 | 6 | 0.80 | 46.13 |  |
| 162 | Current Enzyme Inhibition | journal | 0.170 Q4 | 19 | 23 | 51 | 1435 | 17 | 44 | 0.33 | 62.39 | |
| 161 | Current Cancer Therapy Reviews | journal | 0.183 Q4 | 17 | 21 | 86 | 1067 | 27 | 78 | 0.25 | 50.81 | |
| 160 | MCB Molecular and Cellular Biomechanics | journal | 0.187 Q4 | 31 | 8 | 44 | 308 | 39 | 44 | 0.64 | 38.50 | |
| 159 | Pteridines | journal | 0.192 Q4 | 19 | 9 | 59 | 387 | 25 | 58 | 0.63 | 43.00 | |
| 158 | Yaoxue Xuebao | journal | 0.199 Q4 | 36 | 271 | 786 | 7355 | 439 | 786 | 0.56 | 27.14 | |
| 157 | Journal of Biological Sciences (discontinued) | journal | 0.201 Q4 | 38 | 37 | 188 | 1219 | 108 | 188 | 0.63 | 32.95 |  |
| 156 | Nucleus (India) | journal | 0.203 Q4 | 17 | 24 | 85 | 849 | 37 | 81 | 0.38 | 35.38 | |
| 155 | Drug Discovery Today: Therapeutic Strategies | journal | 0.231 Q4 | 31 | 0 | 22 | 0 | 12 | 20 | 0.00 | 0.00 |  |
| 154 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.236 Q4 | 29 | 6 | 30 | 995 | 46 | 0 | 1.44 | 165.83 | |
| 153 | Current Pharmaceutical Analysis | journal | 0.242 Q4 | 27 | 66 | 121 | 2201 | 110 | 115 | 0.88 | 33.35 | |
| 152 | Current Computer-Aided Drug Design | journal | 0.277 Q4 | 32 | 34 | 134 | 1503 | 145 | 119 | 0.79 | 44.21 | |
| 151 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.296 Q4 | 53 | 66 | 185 | 1679 | 171 | 185 | 0.95 | 25.44 | |
| 150 | Letters in Drug Design and Discovery | journal | 0.313 Q4 | 37 | 134 | 368 | 4847 | 384 | 365 | 1.23 | 36.17 | |
| 149 | International Journal of Peptide Research and Therapeutics | journal | 0.334 Q4 | 45 | 54 | 158 | 2341 | 158 | 157 | 0.96 | 43.35 | |
| 148 | EXCLI Journal | journal | 0.394 Q4 | 55 | 66 | 325 | 2804 | 503 | 272 | 1.50 | 42.48 | |
| 147 | Genomics Data | journal | 0.397 Q4 | 27 | 172 | 388 | 2865 | 319 | 386 | 0.82 | 16.66 | |
| 146 | SAR and QSAR in Environmental Research | journal | 0.412 Q4 | 54 | 58 | 167 | 2439 | 299 | 164 | 1.78 | 42.05 | |
| 145 | Journal of Asian Natural Products Research | journal | 0.413 Q4 | 51 | 145 | 495 | 2916 | 627 | 494 | 1.23 | 20.11 | |
| 144 | Open Medicinal Chemistry Journal | journal | 0.431 Q4 | 23 | 4 | 14 | 187 | 31 | 14 | 2.14 | 46.75 | |
| 143 | Cellular Oncology | journal | 0.433 Q4 | 44 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 142 | Biotechnology and Applied Biochemistry | journal | 0.442 Q4 | 81 | 102 | 264 | 3968 | 380 | 262 | 1.31 | 38.90 | |
| 141 | Molecular Therapy - Oncolytics | journal | 0.452 Q3 | 42 | 38 | 28 | 1858 | 39 | 27 | 1.39 | 48.89 | |
| 140 | Probiotics and Antimicrobial Proteins | journal | 0.457 Q3 | 52 | 26 | 85 | 1038 | 136 | 84 | 1.93 | 39.92 | |
| 139 | Molecular Imaging | journal | 0.463 Q3 | 66 | 17 | 157 | 627 | 268 | 157 | 1.54 | 36.88 | |
| 138 | Personalized Medicine | journal | 0.464 Q3 | 36 | 64 | 236 | 2994 | 245 | 209 | 0.82 | 46.78 | |
| 137 | Future Cardiology | journal | 0.465 Q3 | 43 | 63 | 259 | 3403 | 242 | 203 | 0.94 | 54.02 | |
| 136 | Drug Discovery Today: Disease Models | journal | 0.479 Q3 | 33 | 32 | 82 | 1405 | 83 | 73 | 0.81 | 43.91 | |
| 135 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.490 Q3 | 39 | 39 | 63 | 1947 | 108 | 50 | 1.78 | 49.92 | |
| 134 | Virologica Sinica | journal | 0.505 Q3 | 47 | 75 | 180 | 2689 | 190 | 127 | 1.15 | 35.85 | |
| 133 | Infectious Disorders - Drug Targets | journal | 0.554 Q3 | 61 | 27 | 99 | 1165 | 146 | 89 | 1.41 | 43.15 | |
| 132 | Chemistry and Biodiversity | journal | 0.565 Q3 | 83 | 185 | 477 | 8004 | 825 | 472 | 1.58 | 43.26 | |
| 131 | Pharmaceutical Biology | journal | 0.575 Q3 | 88 | 394 | 676 | 16529 | 1390 | 676 | 1.98 | 41.95 | |
| 130 | Expert Opinion on Medical Diagnostics | journal | 0.576 Q3 | 28 | 0 | 60 | 0 | 117 | 58 | 0.00 | 0.00 | |
| 129 | Molecular Cytogenetics | journal | 0.576 Q3 | 38 | 87 | 263 | 3235 | 437 | 260 | 1.58 | 37.18 | |
| 128 | Acta Naturae | journal | 0.613 Q3 | 36 | 58 | 153 | 3168 | 295 | 144 | 1.89 | 54.62 |  |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data